Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ISLB 2021 | Liquid biopsy in 2021

Catherine Alix-Panabieres • 21 Oct 2021
ISLB 2021
General

Catherine Alix-Panabieres, PhD, University Medical Center of Montpellier, Montpellier, France, gives an overview of what she will discuss in her awards lecture at the International Society of Liquid Biopsy (ISLB) 2021 Virtual Meeting. This interview took place at the International Society of Liquid Biopsy (ISLB) 2021 Virtual Meeting.

Disclosures

Honorarium from Menarini

More from Catherine Alix-Panabieres

Challenges to implementing liquid biopsy in clinical practice
1:49
Challenges to implementing liquid biopsy in clinical practice
Catherine Alix-Panabieres • 12 Apr 2022
Liquid biopsy: an essential complementary tool to the tissue biopsy
1:45
Liquid biopsy: an essential complementary tool to the tissue biopsy
Catherine Alix-Panabieres • 12 Apr 2022
The importance of studying circulating tumor cell lines
1:19
The importance of studying circulating tumor cell lines
Catherine Alix-Panabieres • 12 Apr 2022
Clinical relevance of lipid biopsy and circulating tumor cells for precision medicine
1:07
Clinical relevance of lipid biopsy and circulating tumor cells for precision medicine
Catherine Alix-Panabieres • 12 Apr 2022

Related Videos

AI governance and validation in robotic cancer surgery
1:12
AI governance and validation in robotic cancer surgery
Marie Hanaoka • 1 Jul 2026
Does toxicity differ between patients treated with SABR for one versus five lesions?
0:39
Does toxicity differ between patients treated with SABR for one versus five lesions?
Robert Olson • 16 May 2026
5-year toxicity following SABR: insights from the SABR-5 trial
0:42
5-year toxicity following SABR: insights from the SABR-5 trial
Robert Olson • 16 May 2026
How should results from the SABR-5 trial guide future SABR studies?
1:05
How should results from the SABR-5 trial guide future SABR studies?
Robert Olson • 16 May 2026
The content of VJOncology is intended for healthcare professionals